Human evidence can mean a controlled clinical study, an observational study, a safety or exposure report, or evidence from a particular finished formulation. Those are different kinds of information.
Human evidence in specific contexts. Human studies are available in defined contexts, but the evidence remains product-, population-, route-, or outcome-specific.
Controlled clinical studies in FDA labeling support pramlintide as an adjunct to mealtime insulin in selected adults with type 1 or type 2 diabetes who have not achieved desired glucose control despite appropriate insulin management.
- Evidence type
- Human evidence
- Form
- SymlinPen injection
- Route
- Subcutaneous
Limits and source
Safe use depends heavily on the labeled insulin context and patient selection. The evidence does not support use as a stand-alone weight-management product or outside clinician-directed diabetes care.
Open source [1]How to interpret the evidence label
More human evidence does not automatically mean better results for a different product, route, population, or purpose. Limited or missing evidence does not prove that a compound has no biological activity; it means the relevant clinical question has not been established by the published material reviewed here.
